Epidemiology of Latent Tuberculosis in Rheumatic Immune-Mediated Inflammatory Diseases—Study of 1117 Patients and Descriptive Literature Review

Joy Selene Osorio-Chávez, David Martínez-López, Carmen Álvarez-Reguera, Virginia Portilla, José Manuel Cifrián, Santos Castañeda, Iván Ferraz-Amaro, Ricardo Blanco, Shunsuke Mori · 2024

Read Epidemiology of Latent Tuberculosis in Rheumatic Immune-Mediated Inflammatory Diseases—Study of 1117 Patients and Descriptive Literature Review by Joy Selene Osorio-Chávez, David Martínez-López, Carmen Álvarez-Reguera, Virginia Portilla, José Manuel Cifrián, Santos Castañeda, Iván Ferraz-Amaro, Ricardo Blanco, Shunsuke Mori (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11728139.txt.

Description

Patients with rheumatic immune-mediated diseases risk waking latent tuberculosis when they start biological therapy, so screening is standard. The authors studied 1,117 such patients tested with a skin test, a blood interferon assay, or both, between 2016 and 2020, with a booster skin test after a negative first one. They also reviewed published prevalence figures.

Latent tuberculosis prevalence came to 31.7 percent overall, ranging from 38.5 percent in vasculitis to 14 percent in sarcoidosis. The booster turned positive in 22.9 percent of patients whose blood test was negative or unclear, while the blood test caught 3.8 percent of booster-negative patients. Agreement between the skin-plus-booster approach and the blood test was moderate. The authors recommend using both tests before biological therapy.

Catalog record

CREATORJoy Selene Osorio-Chávez, David Martínez-López, Carmen Álvarez-Reguera, Virginia Portilla, José Manuel Cifrián, Santos Castañeda, Iván Ferraz-Amaro, Ricardo Blanco, Shunsuke Mori
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11728139

Browse the full library · About the Tower of Babel